Skip to main content

HCA Healthcare, Inc.

corporate_fare Company Profile

HCA Healthcare, Inc.

HCA·NYSE·Life Sciences·CIK 0000860730

HCA Healthcare, Inc. is a leading healthcare services company in the United States. As of December 31, 2025, the company operated 190 hospitals, which included 179 general acute care hospitals, seven behavioral hospitals, and four rehabilitation hospitals. Additionally, HCA Healthcare operated 121 freestanding ambulatory surgery centers and 31 freestanding endoscopy centers. Its facilities are located across 19 states and England. The company's primary goal is to deliver a wide range of quality healthcare services as cost-effectively as possible. Its general acute care hospitals offer comprehensive services for medical specialties such as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics, and obstetrics, alongside diagnostic and emergency services. Outpatient and supporting healthcare services are provided through its general acute care hospitals, ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, physician practices, diagnostic centers, home health agencies, hospices, and rehabilitation facilities, among others. The behavioral hospitals provide a full spectrum of mental health care services in inpatient, partial hospitalization, and outpatient settings. HCA Healthcare, Inc. was incorporated in Delaware in October 2010, building on operations that began in 1968 through its predecessors. Its common stock is traded on the New York Stock Exchange under the symbol "HCA."

HCA Healthcare, Inc. (NYSE:HCA) is a publicly traded company in the Life Sciences sector. Wiseek monitors HCA SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • 10% Owner Patricia F. Elcan Reports Major Share Reorganization at HCA Healthcare
  • HCA Healthcare Reports Strong 2025 Financials, Authorizes New $10 Billion Share Repurchase Program, and Increases Quarterly Dividend
  • HCA Healthcare Reports Strong Q4 Results, Authorizes $10 Billion Share Repurchase, and Issues Positive 2026 Guidance

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$75.6B
Net Income
$6.78B
Diluted EPS
$28.33
Op. Cash Flow
$12.64B
Free Cash Flow
$7.69B
Cash & Equivalents
$1.04B
Total Debt
$46.49B
Debt / Equity
-7.71×
Net Margin
9.0%
Shares Outstanding
224.61M sh
Source: 10-K · filed 2026-02-10 · accession 0001193125-26-044769
$377.42 -4.77% today
52-week range · as of 2026-07-24 $330 – $556.52
Market cap
$84.78B
Volume
2.7M (1.6× avg)
3-mo avg 1.7M
Live data · 2026-07-27 03:10 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed HCA - Filings & News (Page 2)

HCA
Feb 10, 2026, 8:05 PM EST
Filing Type: 4
Importance Score:
8
Price at Filing: $502.05
Real-time Price: $377.42 info
Change: -$124.63 (-25%) info
Market Cap: $84.785B info
HCA
Feb 10, 2026, 4:27 PM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $502.05
Real-time Price: $377.42 info
Change: -$124.63 (-25%) info
Market Cap: $84.785B info
HCA
Jan 27, 2026, 7:12 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $473.00
Real-time Price: $377.42 info
Change: -$95.58 (-20%) info
Market Cap: $84.785B info